Target intelligence / Profile preview

Immunoglobulin heavy joining 6 (IGHJ6)

Target
IGHJ6
Molecular classification
Immunoglobulin gene segment, Other (not a receptor, enzyme, transporter, transcription factor, or channel)
01

Overview

Immunoglobulin heavy joining 6 (IGHJ6) is one of the joining (J) gene segments in the immunoglobulin heavy-chain locus, which is located on chromosome 14 in humans[2][3][4]. IGHJ6 plays a crucial role in the adaptive immune system, enabling B cells to generate diverse antibodies through V(D)J recombination—a process that re-arranges variable (V), diversity (D), and joining (J) gene segments to form the variable region of immunoglobulin heavy chains[1][2]. This diversity is fundamental to the body's ability to recognize and respond to a broad array of antigens. Polymorphisms and variation in IGHJ6 and other IGH gene segments can impact individual immune responses and have been associated with differences in disease susceptibility and therapeutic antibody effectiveness[2]. IGHJ6 itself is not a therapeutic target but is critical for antibody repertoire formation in B cells. Neither drugs nor therapeutic mechanisms act directly on this segment, though its genetic variation is studied in immunogenetics and immune response research[2][3].

Other names
JH6bIGHJ6Immunoglobulin heavy chain J6
02

Biological functions

Generation of antibody diversity (via V(D)J recombination)Adaptive immune response
03

Disease associations

Other (variation in IGHJ6 and related segments affects immunoglobulin repertoire, impacting differential disease outcomes, antibody responsiveness, and potentially susceptibility to infection or autoimmunity)

Beyond the preview

Go deeper on Immunoglobulin heavy joining 6 (IGHJ6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy joining 6 (IGHJ6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call